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In a previous editorial, we described the outbreak of the 
first influenza pandemic of the 21st century, which was 
caused by a new variant of the AH1N1v virus. On the 
basis of the first observations, we attempted to forecast 
the most probable evolution of this phenomenon [1]. 
Three months later, it now seems useful to take stock of 
what has happened, in order to evaluate and utilize the 
experience gained.
In those three months, the AH1N1v virus spread to 
almost all countries in the world. However, the epide-
miological scenario differed on account of factors that 
cannot all be explained. In North America (USA [2], 
Mexico [3] and Canada [4]), where the first outbreaks 
were reported, an initial rapid rise in the number of cas-
es (May, 2009) was followed by a more gradual spread 
of the disease. At the end of August, however, infections 
again accelerated and continued to rise up to the end of 
September. The hospitalization rate of laboratory-con-
firmed cases among 5-17-year-old patients exceeded 
that of seasonal influenza, while it was markedly lower 
in the over- 65 age-group.
The pandemic virus reached the temperate zones of the 
southern hemisphere (Argentina, Chile, Australia, etc.) 
right at the beginning of the winter season, and practi-
cally replaced seasonal viruses. Data from the “Sentinel 
general practice survey” of the Ministry of Health in 
New Zealand show that the rate of consultations for 
ILI (Influenza-Like Illness) was higher than that of the 
seasonal peak in the two previous years. The epidemic 
began in June (24th week) and reached its peak in July 
(29th week); it subsequently began to decline, returning 
to baseline values in September (39th week) [5]. The 
Australian Ministry of Health underlined the different 
age-distribution of the virologically confirmed cases in 
comparison with seasonal forms of influenza. Indeed, 
the median age of all patients affected was 21 years; 
that of hospitalized patients was 32 years; that of those 
hospitalized in intensive care units was 44 years, and 
that of those who died was 53 years. This means that 
these patients were much younger than those affected 
by seasonal influenza in the previous two years. Moreo-
ver, pregnant women proved to be particularly at risk of 
H1N1v infection; indeed 25% of women aged between 
15 and 44 years who requested hospitalization were 
pregnant [6].
In the tropical zones of the southern hemisphere, 
where influenza is usually less affected by the climate 
factor, Central and South America were hit hard; how-
ever, the pandemic is currently stable or declining. It 
is noteworthy that cases of co-infection by the H1N1v 
and Dengue viruses have been found in Barbados and 
Nicaragua.
Europe in general, and Italy in particular, were affected 
relatively slightly during the summer period, in spite of 
the numerous cases imported from areas of outbreaks. 
The only exception was the United Kingdom, where the 
new influenza peaked in July 2009 [7].
In sum, the 2009 A/H1N1v pandemic displayed the fol-
lowing features:
• very high incidence in the 4-18-year age-group and 
very low incidence among the over 60s;
• a less close link with the factor “winter” than sea-
sonal influenza;
• the “severity” of the pandemic, as assessed by means 
of WHO criteria, was slight in countries with a good 
qualitative level of healthcare organization;
• the new A/H1N1v virus predominated over seasonal 
subtypes in the period considered;
• no significant mutations of the genome of the pan-
demic virus were detected in this period;
• resistance of the A/H1N1v strain to Oseltamivir has 
so far proved to be rare and sporadic, the majority 
of resistant strains being isolated from immunode-
pressed subjects;
• no epidemics triggered by Oseltamivir-resistant viral 
strains have been reported;
• in several developed countries, an A/H1N1v vaccine 
availability has been announced for the mid October 
2009;
• the rapid preparation of the vaccine, which has 
its cultural and experimental roots in the vaccine 
against the avian influenza virus A/H5N1, consti-
tutes a historic event and provides a very important 
weapon against the spread of the pandemic.
However, some important questions remain open:
• Will we have only one pandemic or will we see suc-
cessive waves?
• Will the prevalence of the infection chiefly remain 
confined to the younger age-groups in Europe too, 
or will adult and elderly populations also be signifi-
cantly involved?
• Will the pathogenicity of the virus remain un-
changed, or will variants be selected that make the 
pandemic more severe, as has happened in every 
pandemic since 1889 [8]?
•  What role will be played by seasonal strains, particu-
larly those of the B viruses and of the H3N2 subtype 
viruses?
•  Will it be possible to modify the trend of the pan-
demic by means of astute use of the vaccine?
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In conclusion, to echo the advice of a well-known Eng-
lish saying: “Hope for the best, prepare for the worst, 
take what comes”, it seems logical that the task of public 
health services is to prepare for the worst. If the virus 
cooperates (by remaining “well-behaved”), we will have 
good reason to be thankful.
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